Sel’skokhozyaistvennaya Biologiya [Agricultural Biology], 2016, V. 51, № 4, pp. 475-482.

doi: 10.15389/agrobiology.2016.4.475eng

UDC 636.2:575.174.015.3:578.2:577.2.08:51-76

 

THE INFECTION HAZARD OF CARRIERS OF PROVIRAL
BOVINE LEUKEMIA VIRUS AND ITS EVALUATION WITH
REGARD TO LEUKOCYTOSIS

G.Yu. Kosovskii1, V.I. Glazko1,2, I.А. Andreichenko1, S.N. Koval’chuk1,
T.T. Glazko1,2

1Center for Experimental Embryology and Reproductive Biotechnology, Federal Agency of Scientific Organizations, 12/4, ul. Kostyakova, Moscow, 127422 Russia,
e-mail gkosovsky@mail.ru, vglazko@yahoo.com, s.n.kovalchuk@mail.ru, tglazko@rambler.ru;
2K.A. Timiryazev Russian State Agrarian University—Moscow Agrarian Academy, 49, ul. Timiryazevskaya, Moscow, 127550 Russia

Received April 21, 2016

 

The spread of the bovine leukemia virus (BLV) brings significant economic damage to dairy and beef cattle still due to the problems to develop the optimal methods for its prevention. The situation is compounded by the fact that the clinical manifestation of lymphocytic leukemia has been observed in animals during 5 to 10 years after infection in approximately 5-7 % of animals. Subdivision of BLV infected B cells on the producers of mature viral particles and precursors of the formation of lymphomas necessitates of separately consideration of the risk of infecting animals and forecast for development of lymphocytic leukemia. Testing antibodies to viral antigens, or proviruse DNA insertion into the host genomes does not allow to reveal the most dangerous animals in view of their role in the infection spread, which is most essential for its control. In this regard, the particular urgency is the method development to assess the infection hazard from carriers of provirus DNA of bovine leukemia virus, associated with a large number of B lymphocytes, producing mature viral particles. In order to evaluate the possibility of using in these purposes not only testing individual animals on the quantity of viral RNA in blood samples, but the proliferative activity of leucocytes, these two characteristics were compared in the present work. The presence or absence of genome integrated provirus DNA in Black-and-White Holstein cows (n = 57, commercial herd) was evaluated and the group of infected animals was revealed when using primers designed by us for BLV gag and pol genes (G.Yu. Kosovoskii et al., 2013). The relative quantity expression of provirus in individual infected cows using RT-PCR analysis and primers to the fragment of the BLV pol gene were assessed. The counting of leukocytes in blood samples of all cows, included in the analysis, was performed. The number of leucocytes in cows free from infection, with the exception of one cow, was less than 12×109 cells/l. This indicator in infected animals divided the investigated cows into two subgroups — in the first subgroup the leucocyte values did not exceed 17×109 cells/l, in the second subgroup the number of leukocytes was significantly higher, reaching 28×109 cells/l in some animals. It was important to note, that the amount (above 20×109 cells/l) of BLV RNA, sufficient to detect by RT-PCR, was revealed only on the second subgroup. The coincidence of the increased leucocyte amount and the BLV RNA in blood of infected animals indicates that particular these cows represent the greatest infection hazard and suggests that the combination of estimates of the number of leukocytes and RNA BLV can be quite a reliable approach for the herd recovery by priority of their liquidation.

Keywords: bovine leukemia virus, BLV, RT-PCR, provirus DNA, pol gene, leukocytosis, the infection hazard.

 

Full article (Rus)

Full text (Eng)

 

REFERENCES

  1. Sagata N., Yasunaga T., Tsuzuku-Kawamura J., Ohishi K., Ogawa Y., Ikawa Y. Complete nucleotide sequence of the genome of bovine leukemia virus: its evolutionary relationship to other retroviruses. PNAS USA, 1985, 82: 677-68 CrossRef
  2. Mirsky M.L., Olmstead C.A., Da Y., Lewin H.A. The prevalence of proviral bovine leukemia virus in peripheral blood mononuclear cells at two subclinical stages of infection. J. Virol., 1996, 70: 2178-2183.
  3. Schwartz I., Bensaid A., Polack B., Perrin B., Berthelemy M., Levy D. In vivo leukocyte tropism of bovine leukemia virus in sheep and cattle. J. Virol., 1994, 68: 4589-4596.
  4. Gillet N., Florins A., Boxus M., Burteau C., Nigro A., Vandermeers F., Balon H., Bouzar A.B., Defoiche J. Mechanisms of leukemogenesis induced by bovine leukemia virus: prospects for novel anti-retroviral therapies in human. Retrovirology, 2007, 4: 18 CrossRef
  5. Gutiérrez G., Rodríguez S.M., de Brogniez A., Gillet N., Golime R., Burny A., Jaworski J.P., Alvarez I., Vagnoni L., Trono K., Willems L. Vaccination against d-retroviruses: the bovine leukemia virus paradigm. Viruses, 2014, 6(6): 2416-2427 CrossRef
  6. Barez P.Y., de Brogniez A., Carpentier A., Gazon H., Gillet N., Gutiérrez G., Hamaidia M., Jacques J.R., Perike S., Neelature Sriramareddy S., Renotte N., Staumont B., Reichert M., Trono K., Willems L. Recent advances in BLV research. Viruses, 2015, 7(11): 6080-6088 CrossRef
  7. Gillet N.A., Gutiérrez G., Rodriguez S.M., de Brogniez A., Renotte N., Alvarez I., Trono K., Willems L. Massive depletion of Bovine leukemia virus proviral clones located in genomic transcriptionally active sites during primary infection. PLoS Pathog., 2013, 9(10): e1003687 CrossRef
  8. Ikebuchi R., Konnai S., Okagawa T., Nishimori A., Nakahara A., Murata S., Ohashi K. Differences in cellular function and viral protein expression between IgMhigh and IgMlow B-cells in bovine leukemia virus-infected cattle. J. Gen. Virol., 2014, 95: 1832-1842 CrossRef
  9. Gillet N.A., Hamaidia M., de Brogniez A., Gutiérrez G., Renotte N., Reichert M., Trono K., Willems L. The bovine leukemia virus microRNAs permit escape from innate immune response and contribute to viral replication in the natural host. Retrovirology, 2015, 12(Suppl 1): O9 CrossRef
  10. Gillet N.A., Hamaidia M., de Brogniez A., Gutiérrez G., Renotte N., Reichert M., Trono K., Willems L. Bovine leukemia virus small noncoding RNAs are functional elements that regulate replication and contribute to oncogenesis in vivo. PLoS Pathog., 2016, 12(4): e1005588 CrossRef
  11. Rosewick N., Momont M., Durkin K., Takeda H., Caiment F., Cleuter Y., Vernin C., Mortreux F., Wattel E., Burny A., Georges M., Van den Broeke A. Deep sequencing reveals abundant noncanonical retroviral microRNAs in B-cell leukemia/lymphoma. PNAS USA, 2013, 110(6): 2306-2311 CrossRef
  12. Glazko V.I., Kosovskii G.Yu., Glazko T.T. Farm animals, 2016, 2(12): 42-46 (in Russ.).    
  13. Kosovskii G.Yu., Sotnikova E.A., Mudrik N.N., Cuong V.C., Toan T.X., Hoan T.X., Glazko V.I. Veterinariya, 2013, 8: 58-61 (in Russ.).    
  14. Polat M., Takeshima S.N., Hosomichi K., Kim J., Miyasaka T., Yamada K., Arainga M., Murakami T., Matsumoto Y., de la Barra Diaz V., Panei C.J., González E.T., Kanemaki M., Onuma M., Giovambattista G., Aida Y. A new genotype of bovine leukemia virus in South America identified by NGS based whole genome sequencing and molecular evolutionary genetic analysis. Retrovirology, 2016, 13(1): 4 CrossRef
  15. de Brogniez A., Bouzar A.B., Jacques J.-R., Cosse J.-P., Gillet N., Callebaut I., Reichert M., Willems L. Mutation of a single envelope N-linked glycosylation site enhances the pathogenicity of bovine leukemia virus. J. Virol., 2015, 89: 8945-8956 CrossRef
  16. Panei C.J., Takeshima S., Omori T., Nunoya T., Davis W.C., Ishizaki H., Matoba K., Aida Y. Estimation of bovine leukemia virus (BLV) proviral load harbored by lymphocyte subpopulations in BLV infected cattle at the subclinical stage of enzootic bovine leucosis using BLV-CoCoMo-284 qPCR. BMC Vet. Res., 2013, 9: 95. Available http://www.biomedcentral.com/1746-6148/9/95. No date.
  17. Jimba M., Takeshima S.N., Murakami H., Kohara J., Kobayashi N., Matsuhashi T., Ohmori T., Nunoya T., Aida Y. BLV-CoCoMo-qPCR: a useful tool for evaluating bovine leukemia virus infection status. BMCVet.Res., 2012, 8(1): 167 CrossRef
  18. Ohira R., Nakahara A., Konnai S., Okagawa T., Nishimori A., Maekawa N., Ikebuchi R., Kohara J., Murata S., Ohashi K. Bovine leukemia virus reduces anti-viral cytokine activities and NK cytotoxicity by inducing TGF-b secretion from regulatory T cells. Immunity, Inflammation and Disease, 2016, 4(1): 52-63 CrossRef
  19. Duffy S., Shackelton L.A., Holmes E.C. Rates of evolutionary change in viruses: patterns and determinants. Nat. Rev. Genet., 2008, 9: 267-276 CrossRef
  20. Juliarena M.A., Barrios C.N., Ceriani M.C., Esteban E.N. Hot topic: Bovine leukemia virus (BLV)-infected cows with low proviral load are not a source of infection for BLV-free cattle. J. Dairy Sci., 2016, 99(6): 4586-4589 CrossRef
  21. Trueblood E.S., Brown W.C., Palmer G.H., Davis W.C., Stone D.M., McElwain T.F. B-lymphocyte proliferation during bovine leukemia virus-induced persistent lymphocytosis is enhanced by T-lymphocyte-derived interleukin-2. J. Virol., 1998, 72(4): 3169-3177.
  22. Suzuki S., Konnai S., Okagawa T., Ikebuchi R., Shirai T., Sunden Y., Mingala C.N., Murata S., Ohashi K. Expression analysis of Foxp3 in T cells from bovine leukemia virus infected cattle. Microbiol. Immunol.,2013, 57: 600-604 CrossRef
  23. Okagawa T., Konnai S., Ikebuchi R., Suzuki S., Shirai T., Sunden Y., Onuma M., Murata S., Ohashi K. Increased bovine tim-3 and its ligand expressions during bovine leukemia virus infection. Vet. Res.,2012, 43: 45-48 CrossRef
  24. Juliarena M.A., Poli M., Ceriani C., Sala L., Rodríguez E., Gutierrez S., Dolcini G., Odeon A., Esteban E.N. Antibody response against three widespread bovine viruses is not impaired in Holstein cattle carrying bovine leukocyte antigen DRB3.2 alleles associated with bovine leukemia virus resistance. J. Dairy Sci., 2009, 92(1): 375-381 CrossRef

back